| Long-term clinical outcomes of adults with metabolic dysfunction-associated fatty liver disease: a single-centre prospective cohort study with baseline liver biopsy WL Chan, SE Chong, F Chang, LL Lai, KH Chuah, NR Nik Mustapha, ... Hepatology International 17 (4), 870-881, 2023 | 6 | 2023 |
| Fibroscan-AST (FAST) score and other non-invasive tests for the diagnosis of fibrotic non-alcoholic steatohepatitis WL Chan, CVC Kumar, WK Chan Hepatobiliary Surgery and Nutrition 12 (5), 763, 2023 | 3 | 2023 |
| The Impact of Socioeconomic and Ethnic Factors on Chronic Liver Disease WL Chan, KH Chuah Alimentary Pharmacology & Therapeutics 60 (11-12), 1617-1618, 2024 | 2 | 2024 |
| Atypical Presentation of Takotsubo Cardiomyopathy: Stroke as a Predisposing Factor CW Loong, MABM Firdaus, MRM Said, IZ Abidin Medeniyet Medical Journal 35 (3), 266, 2020 | 2 | 2020 |
| LIVERSTAT for risk stratification for patients with metabolic dysfunction‐associated fatty liver disease YW Leow, WL Chan, LL Lai, NRN Mustapha, S Mahadeva, R Quiambao, ... Journal of Gastroenterology and Hepatology 39 (10), 2182-2189, 2024 | | 2024 |
| The use of non-invasive tests compared with histological fibrosis stage in predicting liver-related events in metabolic dysfunction-associated fatty liver disease WL Chan, SE Chong, F Chang, KH Chuah, NRN Mustapha, S Mahadeva, ... Journal of Hepatology 78, S710-S711, 2023 | | 2023 |
